1. Home
  2. SYRS

SYRS

Syros Pharmaceuticals Inc.

Logo Syros Pharmaceuticals Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-17-2024 2:33pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Syros Pharmaceuticals Inc is a biopharmaceutical company committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies.

Founded: 2011 Country:
United States
United States
Employees: N/A City: CAMBRIDGE
Market Cap: 142.6M IPO Year: 2016
Target Price: $14.33 AVG Volume (30 days): 221.3K
Analyst Decision: Strong Buy Number of Analysts: 3
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -5.81 EPS Growth: N/A
52 Week Low/High: $2.09 - $8.17 Next Earning Date: 05-08-2024
Revenue: $9,936,000 Revenue Growth: -33.23%
Revenue Growth (this year): -71.26% Revenue Growth (next year): 1045.73%

Share on Social Networks: